Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor.
McQueeney KE, Salamoun JM, Burnett JC, Barabutis N, Pekic P, Lewandowski SL, Llaneza DC, Cornelison R, Bai Y, Zhang ZY, Catravas JD, Landen CN, Wipf P, Lazo JS, Sharlow ER.
McQueeney KE, et al. Among authors: barabutis n.
Oncotarget. 2017 Dec 30;9(9):8223-8240. doi: 10.18632/oncotarget.23787. eCollection 2018 Feb 2.
Oncotarget. 2017.
PMID: 29492190
Free PMC article.